key: cord-0970780-i7d3wgmq
authors: Corman, Victor M; Drosten, Christian
title: Authors’ response: SARS-CoV-2 detection by real-time RT-PCR
date: 2020-05-28
journal: Euro Surveill
DOI: 10.2807/1560-7917.es.2020.25.21.2001035
sha: c02e6782f95cf536db9b09cbe26691345e17659b
doc_id: 970780
cord_uid: i7d3wgmq

nan

To the editor: We thank Pillonel and colleagues for their comments and suggestions [1] . Their letter contains a most relevant statement: 'These observations based on in silico alignments should be confirmed by wetlaboratory experiments, [...]'. As outlined in our initial work, oligonucleotide design at the time was based on available sequences from severe acute respiratory syndrome coronavirus (SARS-CoV) and bat-derived SARS-related CoV sequences [2] . Our strategy during establishment was to use a synthetic target for the SARS-CoV-2 E gene assay, while validating amplification of a full virus genome RNA using the RdRp assay that is specific for both, SARS-CoV and SARS-CoV-2, with the latter not being available to us in the form of an isolate or clinical sample at the time. Based on experimental validation, it later turned out that the mismatched base pairs do not reduce RT-PCR sensitivity and are not to be seen as the reason for somewhat higher Ct values with the RdRp assay as compared to the E gene assay [3] . This is rather due to the general oligonucleotide design, such as the predicted lower melting temperature of the reverse primer compared to the other oligonucleotides.

In general, mutations or unknown variations within the primer binding regions may influence the performance of RT-PCR assays, as also described for SARS-CoV-2 [4] . Oligonucleotide binding regions should be monitored continuously for their matching to circulating virus strains [5] . Providers of RT-PCR assays should announce oligonucleotide binding sites to enable this type of monitoring.

None declared.

VMC and CD wrote the response letter as first author (VMC) and corresponding author (CD) of the original article.

Letter to the editor: SARS-CoV-2 detection by real-time RT-PCR

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Comparative Performance of SARS-CoV-2 Detection Assays using Seven Different Primer/Probe Sets and One Assay Kit

Failure of the cobas® SARS-CoV-2 (Roche) E-gene assay is associated with a C-to-T transition at position 26340 of the SARS-CoV-2 genome. medRxiv

Assay optimization for molecular detection of Zika virus

License, supplementary material and copyright

This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence and indicate if changes were made.Any supplementary material referenced in the article can be found in the online version.